Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 5CNS 3

Conditions

Sexual Infantilism 3Craniopharyngioma 3Overweight 1Obesity 1

Interventions

Temozolomide 610Radiotherapy 387Bevacizumab 253Magnetic Resonance Spectroscopy 202Cyclophosphamide 177Carboplatin 159Radiosurgery 145Etoposide 132Radiation 120Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 81Lomustine 80Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Exenatide × CNS × Clear all
NCT02860923 2026-05-22

CRANIOEXE

University Hospital, Bordeaux

Phase 3 Completed
42 enrolled
CNS

Craniopharyngioma, Sexual Infantilism

NCT01061775 2019-10-08

Effects of Exenatide on Hypothalamic Obesity

Children's Hospitals and Clinics of Minnesota

Phase 1/2 Completed
19 enrolled 17 charts
CNS

Craniopharyngioma, Sexual Infantilism

NCT01484873 2017-03-03

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Vanderbilt University Medical Center

Phase 2 Completed
10 enrolled 15 charts
CNSOther

Craniopharyngioma, Obesity, Sexual Infantilism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡